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A B S T R A C T
Neuropathic pain (NP) develops because of damage to the peripheral or central nervous system. It results in the
hyperalgesia and allodynia. In the recent years, various researchers have studied the involvement of neuro-
immune system in causing persistence of pain. The absence of synaptic contacts in the sensory ganglion makes
them distinctive in terms of pain related signalling. In sensory ganglia, the neurotransmitters or the other
modulators such as inflammatory substances produced by the ganglion cells, because of an injury, are re-
sponsible for the cross-excitation between neurons and neuron-glial interaction, thus affecting chemical trans-
mission. This chemical transmission is considered mainly responsible for the chronicity and the persistent nature
of neuropathic pain. This review examines the pain signalling due to neurotransmitter or cytokine release within
the sensory ganglia. The specific areas focused on include: 1) the role of neurotransmitters released from the
somata of sensory neurons in pain, 2) neuron-glia interaction and 3) role of cytokines in neuromodulation and
pain.
1. Introduction
Injured peripheral nerves induce neuropathic pain (NP) and neu-
ronal excitability within the sensory ganglia (Ma et al., 2003). Although
there are no synaptic contacts in the peripheral sensory ganglia (Bird
and Lieberman, 1976; Bunge et al., 1979), sensory neuron somata can
exhibit cross-excitation from neighboring neurons in the peripheral
ganglia (Amir and Devor, 1999). A small proportion of primary afferent
neurons in intact dorsal root ganglia (DRGs) fire spontaneously where
peripheral afferent axons were intact. A gentle or firm rubbing of the
foot was shown to be capable of evoking cross-excitation of sensory
neurons (Devor and Wall, 1990). However, the percentage of neurons
undergoing cross-excitation is increased after axotomy and may be re-
lated to NP (Devor and Wall, 1990). Cross-excitation has been reported
to be chemically mediated (Amir and Devor, 1996), although the spe-
cific chemical mediator remains unknown. Both our own and other
previous studies, involving in vivo and in vitro settings, have reported
that neurotransmitters such as substance P (SP), calcitonin gene-related
peptide (CGRP) or adenosine 5′-triphosphate (ATP) are released from
the somata of neurons within the sensory ganglia due to inflammatory
and NP condition (Huang and Neher, 1996; Neubert et al., 2000;
Matsuka et al., 2001; Ulrich-Lai et al., 2001; Matsuka et al., 2007;
Matsuka et al., 2008) (Fig. 1).
The cross-excitation occurring within the sensory ganglion fol-
lowing activation of neurons in one-region results in neurons and glial
cell activation throughout the ganglion (Thalakoti et al., 2007; Dublin
and Hanani, 2007). Activated glial cells release various pro and anti-
inflammatory substances, which regulate the neuronal microenviron-
ment and the neuronal excitability, therefore suggesting a relationship
between glial activation and neurogenic stimulation (Dublin and
Hanani, 2007). Furthermore, CGRP enhances purinergic neuron/glia
communication (Ceruti et al., 2011). Through the use of pain models,
results have shown that there is an increased activity of the satelite glia
cells (SGCs) and an increase in the cytokine level during pain condition
(Thalakoti et al., 2007; Üçeyler et al., 2007).
This review examines the relationship between pain generation and
neurotransmitter or cytokine released within the sensory ganglia during
NP conditions, and examines the future direction of the research into
pathological pain mechanisms.
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2. Neurotransmitter release from the somata of sensory ganglia
Various chemical mediators are expressed from the somata of sen-
sory neurons and are involved in chemical transmission. These sub-
stances include the classical transmitters glutamine, gamma-amino
butyric acid (GABA) (Lazarov, 2002), ATP (Matsuka et al., 2008),
neuropeptides (SP, CGRP, neuropeptide Y), galanin (GAL) (Lazarov,
2002), gaseous neuro-messengers (nitric oxide (NO)), (Stoyanova and
Lazarov, 2005; Kolesár et al., 2006; Fan et al., 2008) and other neu-
roactive molecules (nerve growth factor, brain-derived neurotrophic
factor) (Lazarov, 2002; Buldyrev et al., 2006; Tarsa et al., 2011; Kurata
et al., 2013). It has also been reported that after nerve injury, there is a
change in the expression (up or down-regulation) of these chemical
mediators that may be responsible for neural plasticity (Lazarov, 2002).
An exocytotic vesicular release of ATP occurs from the somata of the
sensory neurons (Burnstock et al., 2007). The ATP released from the
somata of DRG neurons is vesicular following action potential stimu-
lation, which is distinctly different from synaptic release (Zhang et al.,
2007). Non vesicular release of ATP was also suggested based on the
evidence from an experimental set up where a specific test has shown
that ATP was released after treatment with botulinum toxin (BoNT)
which prevents vesicle fusion with the plasma membrane by cleaving
SNAP-25 (25-kD synaptosome-associated protein). ATP was still re-
leased from neurons by action potential firing induced by electrical
stimulation (Fields and Yingchun, 2010; Fields, 2011). ATP is stored in
lysosomes via a vesicular nucleotide transporter (VNUT) and released
into the intercellular space through exocytosis. Thus, indicating the role
of VNUT in ATP accumulation in DRG neurons, especially in small- and
medium-sized, and ATP-mediated nociceptive signaling in DRGs
(Nishida et al., 2014). Conduction of pain due to ATP activated re-
ceptors P2X 3, P2X2 and P2X2/3 as well as P2Y1, P2Y2, P2Y4, P2Y6
and related purines P1 receptors on the neuronal cells of the trigeminal
ganglion (TG) and DRG is well documented in the literature
(Staikopoulos et al., 2007; Ruan and Burnstock, 2003; Shinoda et al.,
2007). The P2X3R is present in small-diameter sensory neurons and
mediates nociceptive responses (Dunn et al., 2001; North, 2002; Xiang
et al., 1998). It has been demonstrated by our research that calcium ion-
dependent ATP release takes place from the TG in vivo as well as from
isolated somata of TG sensory neurons (Matsuka et al., 2001, 2007).
The sciatic nerve entrapment (SNE) injury models resulted in sig-
nificantly high basal ATP on the ipsilateral side as compared to both
contralateral side and naïve rat DRG (Matsuka et al., 2008). To test the
hypotheses that the blockade of the evoked release of ATP after SNE
results from the conversion of extracellular ATP to adenosine and
subsequent activation of A1 receptor (A1R) on DRG neurons, A1R
blocker was used. A robust release of ATP in DRG ipsilateral to SNE in
the presence of A1R antagonist (Matsuka et al., 2008) was noted. This
hypothesis was also supported by other research where A1R agonist
was effectively used in inhibiting trigeminal nociception in animal
models as well as human subjects (Goadsby, 2005; Giffin et al., 2003;
Goadsby et al., 2002).
Neurons in sensory ganglion show immune-reactivity towards
GABA (Nakagawa et al., 2003; Hayasaki et al., 2006). GABA is syn-
thesized within the cell bodies of rat TG neurons and GABA-A receptors
are present on neuronal cell bodies of rat TG (Hayasaki et al., 2006).
Under physiological conditions, peripheral GABA limits transient re-
ceptor potential vanilloid 1 (TRPV1) mediated hyperalgesia. GABA-B’s
analgesic property can result by inhibiting TRPV1 activity. TRPV1 and
GABA-B1 complex are shown to be present on intact sensory neurons.
GABA derived from human blister fluid inhibited the TRPV1 sensitisa-
tion in cultured DRG neurons in GABA-B1-dependent manner (Hanack
et al., 2015). GABA-B receptors activation inhibits the excitability of rat
small diameter TG neurons, which are potential targets for the analgesic
action of baclofen (Takeda et al., 2004). A negative cross-talk between
ionotropic receptors activated by ATP or GABA on DRG neurons is re-
ported. The GABAergic mediated reduction in the excitatory action of
ATP may be considered to be involved in sensory information proces-
sing (Sokolova et al., 2001, 2003). Co-expression of P2X3 and GABA-B
receptor has been shown to be present mainly on small diameter TG
neurons. GABA-B receptor activation could inhibit the ATP induced
excitability of small diameter TG neurons through P2X3 receptors
(Takeda et al., 2013). The GABA-B receptor immune-reactivity is shown
to be present on the SGC also (Takeda et al., 2015). So, the pain gen-
eration may be modified by modulating GABA and ATP secretion and
expression of GABA and purinergic receptors in sensory ganglions.
Modulation of pain signals due to CGRP and SP are well docu-
mented in the literature (Benemei et al., 2009; Russell et al., 2014). SP
and CGRP, which have excitatory effects and depolarize the sensory
neurons (Spigelman and Puil, 1988), have been reported to play a
significant role as co-transmitters that cause pain in humans (Edvinsson
and Uddman, 2005). In one study axotomy of the inferior alveolar
nerve lead to a marked reduction in the total SP and CGRP expression in
TG neurons in the ferret (Elcock et al., 2001). In TG, CGRP is primarily
found in the small- and medium-diameter neurons, and the CGRP re-
ceptors, are found on large diameter TG neurons and satellite glial cells
(Eftekhari and Edvinsson, 2010; Eftekhari et al., 2010). CGRP is ex-
pressed in approximately 45 % of small diameter unmyelinated C-type
DRG neurons (Averill et al., 1995; Ruscheweyh et al., 2007). These
peptidergic nociceptors, which also coexpress SP, represent approxi-
mately one-half of C-type nociceptors. CGRP is also expressed in small-
to-medium–diameter Aδ -type neurons, approximately 70 % of which
are nociceptors, and in some large-diameter Aβ sensory fibers. (Averill
et al., 1995; Ruscheweyh et al., 2007; Lazarov, 2002; Lin et al., 2015).
CGRP expression in axons regenerating from the sites of selective
sural nerve crush injury, in ipsilateral lumbar ganglion perikarya and
their central projections suggested complex forms of neuropeptide-
mediated plasticity with selective expression in sprouts and down-
regulation in perikarya. An apparent induction of intense expression of
CGRP in a small uninjured population of neurons in dorsal root gang-
lion has also been noticed in the same study suggesting cross-excitation
of nociceptors, thus enhancing the nociceptive signals in sensory
ganglion (Li et al., 2004). CGRP can cause activation of cultured tri-
geminal ganglia glial cells leading to an increased inducible nitric oxide
synthases activity and NO release (Li et al., 2008). NO increases the
excitability of neurons and diffuses into the adjacent neurons (Amir and
Fig. 1. Mechanisms of chronic pain in sensory ganglion. Pictorial depiction of
the hypotheses for the chemical mode of neurotransmission in the sensory
ganglion, which may be paracrine or autocrine. This mechanism is responsible
for the abnormal firing of sensory neurons in the ganglion and is responsible for
the maintenance of chronic pain.
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Devor, 1996; Stoyanova and Lazarov, 2005). Whereas, conditioned
medium from SGC activated by IL-1β and NO augments the release of
CGRP from TG neurons (Capuano et al., 2009).
It is well known that NP induces hyperexcitation of injured neurons
and cross-excitation of the neighboring neurons in primary sensory
ganglia (Gold, 2000; Devor, 2006; Dray, 2017). We reported the co-
release of ATP and SP within the TG in vivo by using a micro dialysis
probe (Matsuka et al., 2001). In this experiment, significant reversible
increase in ATP and SP was observed after neuronal stimulation. In our
experiment, we monitored this by using (N-(3-triethylammonium-
propyl)-4-(6-(4- (diethylamino)phenyl)hexatrienyl)pyridinium di-
bromide (FM4-64) in acutely dissociated TG neurons (Matsuka et al.,
2007). The secretory activity of acutely dissociated TG neurons from
naïve and infraorbital nerve constriction (IoNC) rats can be evaluated
by measuring the fluorescence intensity of the membrane-uptake
marker FM4-64 (Kitamura et al., 2009). FM4-64 dyes reveal membrane
turnover of neurons following stimulation, thus showing the vesicular
release of neurotransmitters. These vesicles release neurotransmitters
when they fuse with the plasma membrane (exocytosis), and they be-
come ready for another cycle of release after being regenerated from
the plasma membrane (endocytosis) and reloaded with neuro-
transmitters. Thus, the changes in FM fluorescence intensity are in-
dicators of vesicle exo- and endocytosis (Iwabuchi et al., 2014). We
observed two different vesicular release pattern suggesting secretion of
different compounds from different neuron subgroups (Matsuka et al.,
2007). BoNT has been reported to block vesicular neurotransmitter
release by disabling the soluble N-ethylmaleimide sensitive factor at-
tachment protein receptor complex proteins that mediate the vesicular
transmitter release (Niemann et al., 1994; Schiavo et al., 2000). We
observed that there was a significantly reduced rate of FM4-64 dye
release in BoNT pretreated acutely dissociated TG neurons from naïve
rats. In addition, the TG neurons with IoNC exhibited a faster onset of
FM4-64 release compared to the contralateral side of IoNC (Kitamura
et al., 2009). Peripheral intradermal injections of BoNT in the facial
area of rats decreased the IoNC-induced pain behavior and reduced the
exaggerated FM4-64 release from the TG neurons (Kumada et al.,
2012). Thus, the results of these experiments showed that evoked ve-
sicular release of neurotransmitters was inhibited by BoNT. In another
experimental set-up, direct application of BoNT to the ipsilateral L4
DRG led to a reversal of the sciatic nerve entrapment (SNE)-induced
pain behavior within 2 days. Histologically BoNT was localized in the
cell bodies of the DRG thus strengthening the evidence that neuro-
transmitter release is responsible for causing pain and its blockade may
relief the pain symptoms (Omoto et al., 2015). Additional studies have
reported on various other neurotransmitters involved in pain initiation
and maintenance in the sensory ganglion, such as somatostatin (Takeda
et al., 2007; Takahashi et al., 2014), galanin, (Shi et al., 2006) or no-
ciceptin (Hou et al., 2003).
3. Glial cell involvement in pain - neuron-glia interaction in
sensory ganglia
Activation of the sensory neurons leads to changes in the adjacent
glia (Fig. 2), which involves communication through gap junctions and
paracrine signaling. A retrograde tracer True Blue dye was detected in
both the neuronal cell bodies and the adjacent glia in the TG following
capsaicin stimulation of peripheral facial site (Thalakoti et al., 2007).
The involvement of the glial cells in the initiation and maintenance of
the neuronal changes that underlie the NP has been referred to as
“gliopathic pain” (Ohara et al., 2009). Activation of glial cells in the
peripheral nervous system leads to an increased in the level of glial
fibrillary acidic protein (GFAP), a definitive marker for glial cell acti-
vation, in the DRG and trigeminal nerve injury model (Vit et al., 2006;
Xie et al., 2009; Katagiri et al., 2012; Donegan et al., 2013; Matsuura
et al., 2013; Souza et al., 2013; Hanani et al., 2014; Gong et al., 2015).
These activated SGCs release substances that may contribute to the
sustainment of the pain state. ATP is reported to be the main mediator
of the interaction between the neuron and the glia (Gu et al., 2010;
Suadicani et al., 2010). The SGC express P2Y1, P2Y2, P2Y4, P2Y6,
P2Y12 and P2Y13 receptors (Katagiri et al., 2012; Weick et al., 2003;
Ceruti et al., 2008; Magni et al., 2015) and exhibit an inflammation-
induced change in the sensitivity of SGCs to ATP involving P2X re-
ceptors (Zhang et al., 2007; Kushnir et al., 2011; Nowodworska et al.,
2017). The exclusive expression of P2X3R in neurons and P2X7R in
SGCs facilitates the communication between neuronal somata and SGCs
(Chen et al., 2008; Kobayashi et al. 2005; Zhang et al., 2005; Dunn
et al., 2001; Nakatsuka and Gu, 2006). Neuron-glia interaction is ac-
complished by ATP released from the neuronal soma and activation of
P2X7Rs in SGCs (Gu et al., 2010; Zhang et al., 2007). Neuron-glia sig-
naling due to CGRP released from the neuronal soma occurs due to
activation of CGRP receptors (calcitonin receptor like receptor (CRLR)
and receptor activity modifying protein 1 (RAMP1)) present on satellite
glial cells and neurons (Eftekhari and Edvinsson, 2010; Eftekhari et al.,
2010). Moreover, CGRP also potentiates the purinergic P2Y receptors
on the SGCs (Ceruti et al., 2011). Presence of the N-methyl-D-aspartate
receptor (NMDAr) on SGCs and on the neurons may also contribute to
neuron-glia interactions due to glutamatergic transmission contributing
to pain initiation and maintenance after nerve injury (Castillo et al.,
2013; Marvizón et al., 2002; Kung et al., 2013). Under the normal
resting condition, GABA is synthesized in the neuronal cell body, re-
leased at the interface and taken up and stored by SGC and can be
released on subsequent neuron-glial activation (Nakagawa et al., 2003;
Hayasaki et al., 2006). Nucleotides secreted by TG neurons increase the
calcium concentration inside the SGC, which may be responsible for
cross-excitation and pain generation (Costa and Neto, 2015).
Glial cells represent the intrinsic innate immune cells of the central
nervous system and peripheral nervous system (Vezzani and Viviani,
2015). The results of various studies have shown that SGCs of sensory
ganglion have the properties of tissue-resident antigen presenting cells
expressing the common leukocyte marker CD45, the macrophage
markers CD14, CD68 and CD11b, the myeloid dendritic cell marker
CD11c, the T cell co-stimulatory molecules CD40, CD 54, CD80 and
CD86 and major histocompatibility complex class II molecules and toll-
like receptors (TLR) especially TLR 2 and 3. Production of pro-in-
flammatory cytokines IL-6 from glial cells in response to stimulation by
TLR 1–5 ligands was also demonstrated (van Velzen et al., 2009;
Mitterreiter et al., 2017). Thus, by activating their cognate receptors on
neurons these inflammatory substances secreted from the glial cells also
contribute to neuron-glia signaling (Takeda et al., 2008). Apart from
producing cytokines, SGCs have also been reported to be activated by
monocyte chemotactic protein (MCP-1) via CCR-2 receptor, which is
similar to that seen in the immune cells (Jeon et al., 2008).
4. Cytokines/chemokines and neuron-glia cross-talk – pain due to
sterile inflammation
Release of inflammatory cytokines from the activated glial cells in
the absence of infection is also known as sterile inflammation and may
be responsible for the persistence of pain. By engaging their respective
receptors on neurons, the cytokines released from the glial cells may
modulate the excitability of neurons, thus contributing to neuron-glia
signaling (Takeda et al., 2008). Hence, the released cytokines/chemo-
kines may be regarded as novel neuromodulators (Vezzani and Viviani,
2015) (Fig. 2).
Evidence recorded from various cell culture studies showed differ-
ential responsiveness from neurons of DRG (Binshtok et al., 2008; Chen
et al., 2011; Czeschik et al., 2008; He et al., 2010; Jin and Gereau, 2006;
Tamura et al., 2014) and TG (Takeda et al., 2008), following exogenous
application of cytokines to neurons signifying the neuromodulatory
effect of cytokines on pain.The release of various cytokines and in-
creased expression of multiple mitogen-activated protein kinases
(MAPK) signalling from glial rich culture of TG after stimulation with
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CGRP has been demonstrated (Afroz et al., 2019; Ceruti et al., 2011;
Thalakoti et al., 2007; Vause and Durham, 2012, 2010). Lipopoly-
saccharide (LPS) primed schwann cells from mouse DRG were shown to
synthesize large amounts of IL-1β (Colomar et al., 2003). When the SGC
from TG were exposed to IL-1β or NO donor namely diethylene-
triamine/nitric oxide, an increased prostaglandin E2 (PGE2) release
was observed from SGCs. Subsequently, conditioned medium harvested
from activated SGC was used to test possible modulatory effects of glial
factors on trigeminal neuronal activity, which resulted in an evoked
release of CGRP by trigeminal neurons (Capuano et al., 2009). In-vitro
incubation of SGC with fractalkine induced the production and release
of Tumor necrosis factor-α (TNFα), IL-1β and PGE2 (Souza et al., 2013).
Activation of transient receptor potential melastatin (TRPM2) under
oxidative stress lead to increased expression of IL-6 and CXCL2 in dis-
sociated TG. TRPM2 was found to be expressed on both neurons and
SGC, and the treatment of SGC with H2O2 significantly up-regulated IL-
6 and CXCL2 gene expression (Chung et al., 2015).
Various animal pain models are used to study the cytokine/che-
mokine related neuron-glia interaction in sensory ganglion. The ex-
pression of various cytokines and proteins from TG ganglion and spinal
trigeminal nuclei are increased as demonstrated by protein array ana-
lysis after capsaicin injection in the ophthalmic division of trigeminal
nerve region (Vause and Durham, 2012). Similarly, in an animal model
of prolonged jaw opening simulating TMD following lengthy dental
appointments, differential cytokine expression was detected in the TG
and upper cervical spinal cord. This increase in cytokine expression was
consistent with the nocifensive head withdrawal to mechanical stimuli
in the masseter muscle region (Hawkins and Durham, 2016). Dysre-
gulation of numerous serum cytokines and microglial activation, in the
spinal trigeminal nucleus in the TNFR1/2 knock out mouse, with tri-
geminal inflammatory compression model, was identified. P38, MAPK
inhibitor and minocycline a glial inhibitor reduced mechanical hy-
persensitization thus produced (Ma et al., 2015). Use of a restraint
stress animal model had shown to activate the SGCs, which led to a
release of IL-1β in the TG, thereby causing masseter muscle allodynia
(Zhao et al., 2015). This study additionally showed that injection of L-α
aminoadipate (an SGC inhibitor) in the TG ganglion significantly atte-
nuated the masseter allodynia. In orofacial NP model created by IoNC,
the effect of Pregabalin (PG) and Diclofenac on the pain behavior and
pro-inflammatory cytokines showed that pain induced by the nerve
injury and IL-1β was significantly reduced by PG, and this effect was
dose-dependent (Khan et al., 2018). In another study, IoNC was ac-
companied with pain behaviour and glial activation. Pro-inflammatory
cytokine CXCL2 levels were increased during the early phase of neu-
ropathic pain induction and decreased gradually, while anti-in-
flammatory cytokine IL-10 levels showed the opposite trend. Re-
combinant IL-10 or anti-CXCL2 injection into trigeminal ganglia in an
IoNC model decreased pain behaviour (Iwasa et al., 2019). In-
traganglionar (IG) injection of CGRP in TG resulted in increased sen-
sitivity to heat, neuronal and glial activation, and a time related dif-
ferential regulation of cytokines (increase in mRNA expression of IL-1β
and IL-1RA) in the TG. All these effects were reversed when minocy-
cline was administered before CGPR IG (Afroz et al., 2019). Chronic
constriction injury (CCI) of the sciatic nerve showed an increased
mRNA expression of the pro-inflammatory cytokines TNF-α, IL-1β and
the anti-inflammatory cytokines IL-4, IL-10 in DRG (Üçeyler et al.,
2007). Increased expressions of TNF-α and the TNF-α1 receptor on the
neurons and the associated SGCs have been reported in an animal pain
model (Ohtori et al., 2004; Dubový et al., 2006). Furthermore, TNF-α
activates SGCs, which leads to increased phosphorylation of the protein
kinase regulated extracellular signals (ERK) in the DRG (Takahashi
et al., 2006). The increased activation of this protein in SGCs after a
nerve injury in the DRG has been shown to be associated with chronic
pain (Doya et al., 2005). Intradermal injection of capsaicin in hind paw
induced hyper-excitability of DRG neurons and glia activation. Pre-
treatment with minocycline inhibited glial activation and neuronal
excitability. This effect was mainly mediated by inhibiting the synth-
eses of TNF-α in SGC and blocking the up-regulation of TNFR1s in
Fig. 2. The interaction between the sensory neurons and the glial cells. Hypothetical interpretation of the interaction between the neuron and glial cells in the
sensory ganglion due to chemical transmission.
Y. Matsuka, et al. Neuroscience and Biobehavioral Reviews 108 (2020) 393–399
396
neurons with more potent effect observed on SGC (Gong et al., 2015).
IG fractalkine injection (DRG) induced mechanical hypernociception
was attenuated by treatment with neutralizing antibody against
CX3CR1 and fractalkine, and pretreatment with fluorocitrate (IG), a
glial inhibitor, showing possible SGCs involvement. IG injection of
thalidomide and infliximab (anti-TNF-α therapies), IL-1 receptor an-
tagonist and indomethacin (cyclooxygenase inhibitor) reduced the
carrageenan and IG fractalkine induced mechanical hypernociception,
suggesting the involvement of TNF-α, IL-1β, and prostaglandins (Souza
et al., 2013). In an NP model of rat DRG, IL-6 and the corresponding
signal transducing receptor were expressed in the SGCs (Dubovy et al.,
2010). Bilateral increase in IL-6 protein and mRNA in unilateral CCI of
sciatic nerve in lumbar and cervical DRG was also reported (Dubový
et al., 2013). The results of some studies show that CXCL-12/CXCR4
signalling is found to be enhanced in DRG after chronic compression of
DRG. In this study, CXCR4 was detected in DRG neurons, but not in
SGC. The mechanical and thermal hypernociception was alleviated by
administration of CXCR4 antagonist AMD3100 (Yu et al., 2017).
However, one study reported the increased expression of CXCL-12 and
its cognate receptor CXCR4 in DRG neurons as well as SGCs after spared
nerve injury (SNI). SNI also increased the sustained expression of TNF-α
in DRG and spinal cord. Intraperitoneal administration of the TNF-α
synthesis inhibitor thalidomide reduced the SNI-induced mechanical
hypersensitivity and inhibited the expression of CXCL-12 in the DRG
and spinal cord. Thus, indirectly indicating the effect of TNF-α upre-
gulation on CXCL-12 expression. (Bai et al., 2016).
5. Conclusion
Various studies provide the necessary evidence to support the role
of chemical messengers, secreted by neurons and SGC, in genesis and
maintenance of pain in sensory ganglion. These chemical messengers
are involved in modulating the microenvironment in sensory ganglion
leading to the neuron-glia interaction. This provides the evidence of
availability of various targets and probability of exploring more such
targets, which can be manipulated by various drugs to control the pain
signals in the sensory ganglion.
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